Safety of sublingual immunotherapy started during the pollen season

Author： Ariano Renato   Incorvaia Cristoforo   La Grutta Stefania   Marcucci Francesco   Pajno Giovanbattista   Sensi Laura   Di Cara Giuseppe   Sieber Jochen   Yacoub Mona-Rita   Frati Franco  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.1, 2009-01, pp. : 103-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Various Dosage Regimens during Induction of Sublingual Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 129, Iss. 3, 2002-11 ,pp. : 248-253

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Juniperus ashei Sublingual-Swallow Ultra-Rush Pollen Immunotherapy in Cypress Rhinoconjunctivitis

By  

International Archives of Allergy and Immunology, Vol. 142, Iss. 3, 2006-11 ,pp. : 239-246

Karger

Access to resources Recommend Favorite

The Safety of Allergen Specific Sublingual Immunotherapy

By  

Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. : 117-123

Bentham Science Publishers

Access to resources Recommend Favorite

Adverse Events During Immunotherapy Against Grass Pollen‐Induced Allergic Rhinitis – Differences Between Subcutaneous and Sublingual Treatment

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 2, 2015-08 ,pp. : 73-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systemic Immunological Changes Induced by Administration of Grass Pollen Allergens via the Oral Mucosa during Sublingual Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 120, Iss. 3, 1999-11 ,pp. : 218-224

Karger

Access to resources Recommend Favorite